Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessHighly AccessResearch

Intensive care adult patients with severe respiratory failure caused by Influenza A (H1N1)v in Spain

Jordi Rello1 email, Alejandro Rodríguez1 email, Pedro Ibañez2 email, Lorenzo Socias2 email, Javier Cebrian3 email, Asunción Marques4 email, José Guerrero5 email, Sergio Ruiz-Santana6 email, Enrique Marquez7 email, Frutos Del Nogal-Saez8 email, Francisco Alvarez-Lerma9 email, Sergio Martínez10 email, Miquel Ferrer11 email, Manuel Avellanas12 email, Rosa Granada13 email, Enrique Maraví-Poma14 email, Patricia Albert15 email, Rafael Sierra16 email, Loreto Vidaur17 email, Patricia Ortiz18 email, Isidro Prieto del Portillo19 email, Beatriz Galván20 email and Cristóbal León-Gil21 email for the H1N1 SEMICYUC working group

1Critical Care Department, Joan XXIII University Hospital, CIBERes Enfermedades Respiratorias. IISPV. Mallafre Guasch 4 (43007)Tarragona, Spain

2Critical Care Department, Son Llatzer Hospital, Crta. Manacor Km 4, (07198) Palma de Mallorca, Spain

3La Fe Hospital, CIBERES, Av. Campanar 21 (46009) Valencia, Spain

4De la Ribera Hospital. Crta. de Corbera Km 1 (46600) Alzira, Valencia, Spain

5Gregorio Marañón Hospital, CIBERES, Calle Doctor Esquerdo 46 (28004) Madrid, Spain

6Dr. Negrín Hospital, Barranco de la Ballena s/n (35010) Las Palmas de Gran Canarias, Spain

7Infanta Elena, C/Red Corp, J. Andalucía s/n, (21700) Huelva, Spain

8Severo Ochoa Hospital, Avd. de Orellana s/n (28911) Leganés, Madrid, Spain

9Del Mar Hospital, CIBERES, Passeig Maritim 25-29 (08003) Barcelona, Spain

10Insular Hospital de Gran Canarias, Carretera del Sur s/n (35016) Las Palmas de Gran Canarias, Spain

11Clinic Hospital, IDIBAPS, CIBERES Enfermedades Respiratorias, C/Villarroel 170 (08036) Barcelona, Spain

12San Jorge General Hospital, Av. Martínez de Velazco 36 (22004) Huesca, Spain

13Bellvitge University Hospital, CIBERES, Feixa Llarga s/n (08907) Barcelona, Spain

14Virgen del Camino Hospital, C/de Irunlarrea 4 (31008) Navarra, Spain

15Hospital del Sureste, Ronda del Sur 10 (28500) Arganda del Rey, Madrid, Spain

16Puerta del Mar Hospital, Avda Ana de Viya 21 (11009) Cádiz, Spain

17Hospital Donostia, Paseo Dr. José Beguiristain s/n (20014) Donostia, San Sebastian, Spain

18Josep Trueta University Hospital, Avda. França s/n (17007) Girona, Spain

19Ramón y Cajal University Hospital, Ctra. De Colmenar Viejo Km 9,100 (28034) Madrid, Spain

20La Paz University Hospital, P de la Castellana 261 (28046) Madrid, Spain

21Hospital Nuestra Señora de Valme, Ctra. Cádiz-Bellavist Km 548 (41014) Sevilla, Spain

author email corresponding author email

Critical Care 2009, 13:R148doi:10.1186/cc8044

Published: 11 September 2009


See related commentary by Opal, http://ccforum.com/content/13/5/196

Abstract

Introduction

Patients with influenza A (H1N1)v infection have developed rapidly progressive lower respiratory tract disease resulting in respiratory failure. We describe the clinical and epidemiologic characteristics of the first 32 persons reported to be admitted to the intensive care unit (ICU) due to influenza A (H1N1)v infection in Spain.

Methods

We used medical chart reviews to collect data on ICU adult patients reported in a standardized form. Influenza A (H1N1)v infection was confirmed in specimens using real-time reverse transcriptase-polymerase-chain-reaction (RT PCR) assay.

Results

Illness onset of the 32 patients occurred between 23 June and 31 July, 2009. The median age was 36 years (IQR = 31 - 52). Ten (31.2%) were obese, 2 (6.3%) pregnant and 16 (50%) had pre-existing medical complications. Twenty-nine (90.6%) had primary viral pneumonitis, 2 (6.3%) exacerbation of structural respiratory disease and 1 (3.1%) secondary bacterial pneumonia. Twenty-four patients (75.0%) developed multiorgan dysfunction, 7 (21.9%) received renal replacement techniques and 24 (75.0%) required mechanical ventilation. Six patients died within 28 days, with two additional late deaths. Oseltamivir administration delay ranged from 2 to 8 days after illness onset, 31.2% received high-dose (300 mg/day), and treatment duration ranged from 5 to 10 days (mean 8.0 ± 3.3).

Conclusions

Over a 5-week period, influenza A (H1N1)v infection led to ICU admission in 32 adult patients, with frequently observed severe hypoxemia and a relatively high case-fatality rate. Clinicians should be aware of pulmonary complications of influenza A (H1N1)v infection, particularly in pregnant and young obese but previously healthy persons.


© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.